176 related articles for article (PubMed ID: 25490769)
1. Dynamic conformations of nucleophosmin (NPM1) at a key monomer-monomer interface affect oligomer stability and interactions with granzyme B.
Duan-Porter WD; Woods VL; Maurer KD; Li S; Rosen A
PLoS One; 2014; 9(12):e115062. PubMed ID: 25490769
[TBL] [Abstract][Full Text] [Related]
2. Structural polymorphism in the N-terminal oligomerization domain of NPM1.
Mitrea DM; Grace CR; Buljan M; Yun MK; Pytel NJ; Satumba J; Nourse A; Park CG; Madan Babu M; White SW; Kriwacki RW
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4466-71. PubMed ID: 24616519
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin is cleaved and inactivated by the cytotoxic granule protease granzyme M during natural killer cell-mediated killing.
Cullen SP; Afonina IS; Donadini R; Lüthi AU; Medema JP; Bird PI; Martin SJ
J Biol Chem; 2009 Feb; 284(8):5137-47. PubMed ID: 19103589
[TBL] [Abstract][Full Text] [Related]
4. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin in leukemia: Consequences of anchor loss.
Brodská B; Šašinková M; Kuželová K
Int J Biochem Cell Biol; 2019 Jun; 111():52-62. PubMed ID: 31009764
[TBL] [Abstract][Full Text] [Related]
6. Cryptic disorder: an order-disorder transformation regulates the function of nucleophosmin.
Mitrea DM; Kriwacki RW
Pac Symp Biocomput; 2012; ():152-63. PubMed ID: 22174271
[TBL] [Abstract][Full Text] [Related]
7. Human and mouse granzyme M display divergent and species-specific substrate specificities.
de Poot SA; Westgeest M; Hostetter DR; Van Damme P; Plasman K; Demeyer K; Broekhuizen R; Gevaert K; Craik CS; Bovenschen N
Biochem J; 2011 Aug; 437(3):431-42. PubMed ID: 21564021
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation Code of Human Nucleophosmin Includes Four Cryptic Sites for Hierarchical Binding of 14-3-3 Proteins.
Kapitonova AA; Perfilova KV; Cooley RB; Sluchanko NN
J Mol Biol; 2024 Jun; 436(12):168592. PubMed ID: 38702038
[TBL] [Abstract][Full Text] [Related]
10. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the oligomeric states of nucleophosmin using size exclusion chromatography.
Sakashita G; Kiyoi H; Naoe T; Urano T
Sci Rep; 2018 Mar; 8(1):4008. PubMed ID: 29507312
[TBL] [Abstract][Full Text] [Related]
12. Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.
Kuželová K; Brodská B; Fuchs O; Dobrovolná M; Soukup P; Cetkovský P
PLoS One; 2015; 10(5):e0127637. PubMed ID: 25992555
[TBL] [Abstract][Full Text] [Related]
13. Role of nucleophosmin in embryonic development and tumorigenesis.
Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
[TBL] [Abstract][Full Text] [Related]
14. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells.
Qi W; Shakalya K; Stejskal A; Goldman A; Beeck S; Cooke L; Mahadevan D
Oncogene; 2008 Jul; 27(30):4210-20. PubMed ID: 18345031
[TBL] [Abstract][Full Text] [Related]
15. Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells.
Chan PK; Chan FY
Biochim Biophys Acta; 1995 May; 1262(1):37-42. PubMed ID: 7772597
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair.
López DJ; Rodríguez JA; Bañuelos S
Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140532. PubMed ID: 32853771
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.
Chiarella S; De Cola A; Scaglione GL; Carletti E; Graziano V; Barcaroli D; Lo Sterzo C; Di Matteo A; Di Ilio C; Falini B; Arcovito A; De Laurenzi V; Federici L
Nucleic Acids Res; 2013 Mar; 41(5):3228-39. PubMed ID: 23328624
[TBL] [Abstract][Full Text] [Related]
18. NPM1 exhibits structural and dynamic heterogeneity upon phase separation with the p14ARF tumor suppressor.
Gibbs E; Perrone B; Hassan A; Kümmerle R; Kriwacki R
J Magn Reson; 2020 Jan; 310():106646. PubMed ID: 31751897
[TBL] [Abstract][Full Text] [Related]
19. Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling.
Okuwaki M; Sumi A; Hisaoka M; Saotome-Nakamura A; Akashi S; Nishimura Y; Nagata K
Nucleic Acids Res; 2012 Jun; 40(11):4861-78. PubMed ID: 22362753
[TBL] [Abstract][Full Text] [Related]
20. Localization of AML-related nucleophosmin mutant depends on its subtype and is highly affected by its interaction with wild-type NPM.
Brodská B; Kráčmarová M; Holoubek A; Kuželová K
PLoS One; 2017; 12(4):e0175175. PubMed ID: 28384310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]